This company develops temporary cardiac pacing leads for patients experiencing bradycardia after procedures like cardiac surgery. Their pacing lead is designed to provide stable pacing with fewer complications, enabling earlier ambulation and improved patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Temporary cardiac pacing following procedures like cardiac surgery, TAVR, and TMVR is often complicated by lead dislodgement, cardiac perforation, and valve embolization. Conventional temporary pacing leads can be unstable, leading to loss of pace capture and delayed patient mobilization, increasing the length of stay and associated costs.
Solution
The Tempo Temporary Pacing Lead is an active fixation lead designed to provide secure and stable pacing, reducing complications and enabling earlier patient ambulation. The lead features small, retractable stabilizer loops for secure fixation and a soft distal tip to minimize the risk of myocardial perforation. Its design ensures stability during rapid pacing and facilitates patient mobilization in recovery, potentially reducing the length of stay in critical care units.
Target Audience
The primary target audience includes electrophysiologists, cardiothoracic surgeons, and interventional cardiologists who perform procedures requiring temporary cardiac pacing, as well as hospital systems seeking to reduce complications and improve patient outcomes.
Features
- Active fixation mechanism with small atraumatic stabilizer loops deployed and retracted via handle
- Soft distal tip to minimize the risk of myocardial perforation
- Asymmetric elastomeric balloon to aid passage through venous vasculature and wall apposition during stabilizer deployment
- Demonstrated safety and efficacy in a US multi-center study
- High rate of successful placement and pacing
- Low rate of dislodgements in mobilized patients